Effects of Phosphoramidon on Endothelin-1 and Big Endothelin-1 Production in Human Aortic Endothelial Cells
スポンサーリンク
概要
- 論文の詳細を見る
Using cultured human aortic endothelial cells, we examined the effects of phosphoramidon, an endothelin converting enzyme (ECE) inhibitor, on the release of endogenous endothelin-1 (ET-1) and big endothelin-1 (big ET-1), and on the generation of ET-1 from exogenously applied big ET-1. Phosphoramidon, at concentrations of 10^<-6> to 2×10^<-4>M, caused a biphasic alteration of the ET-1 release, i.e., at lower concentrations of the drug, there were slight but unexpected increases of the release, whereas higher concentrations led to a decrease which is due to the drug-induced inhibition of ECE. The former effect appears to be based on the inhibition of ET-1 degradation by neutral endopeptidase 24.11 (NEP), since kelatorphan, a specific NEP inhibitor, produced a similar increasing effect on ET-1 release. Phosphoramidon enhanced the big ET-1 release from the cells in a concentration-dependent manner. When high concentrations of phosphoramidon were added, there was a dramatic increase in the release of big ET-1,which cannot be explained only by the drug-induced inhibition of ECE. This increase in big ET-1 release appeared to be partly due to a transient stimulation of the expression of prepro ET-1 mRNA. The amount of ET-1 generated from exogenously applied big ET-1 was markedly decreased by phosphoramidon in a concentrationdependent manner. In a similar fashion, phosphoramidon markedly inhibited ECE activity of the membrane fraction of cultured cells. Thus, ET-1 generation from exogenously applied big ET-1 reflects the functional phosphoramidon-sensitive ECE activities in human aortic endothelial cells. In contrast, the effect of phosphoramidon on the release of endogenous ET-1 appears to be modified by the drug-induced augmentation of big ET-1 production, as well as by an inhibition of ET-1 degradation.
- 社団法人日本薬学会の論文
- 1995-03-15
著者
-
村田 聡
Department Of Pharmacology Osaka University Of Pharmaceutical Sciences
-
松村 靖夫
Department of Pharmacology, Osaka College of Pharmacy
-
森本 史郎
Department of Pharmacology, Osaka College of Pharmacy
-
高岡 昌徳
Department of Pharmacology, Osaka College of Pharmacy
-
村上 暁子
Department Of Pharmacology Osaka University Of Pharmaceutical Sciences
-
森本 史郎
大阪薬科大学
-
塚原 八重子
Department of Pharmacology, Osaka University of Pharmaceutical Sciences
-
児島 たか代
Department of Pharmacology, Osaka University of Pharmaceutical Sciences
-
高田 貴美
Department of Pharmacology, Osaka University of Pharmaceutical Sciences
-
松村 靖夫
国立循環器病センター研究所 循環分子生理部
-
松村 靖夫
大阪薬科大学
-
Murakami Akiko
Department Of Pharmacology Osaka University Of Pharmaceutical Sciences
-
Murata S
Department Of Pharmacology Osaka University Of Pharmaceutical Sciences
-
Morimoto S
Pharmaceutical Development Laboratories Pharmaceutical Production Division Takeda Chemical Industrie
-
児島 たか代
Department Of Pharmacology Osaka University Of Pharmaceutical Sciences
-
塚原 八重子
Department Of Pharmacology Osaka University Of Pharmaceutical Sciences
-
高田 貴美
Department Of Pharmacology Osaka University Of Pharmaceutical Sciences
-
森本 史郎
Department of Pharmacology, Osaka City University Medical School
関連論文
- ラットおよびマウスにおける腎機能低下モデルの簡便な作製方法 : 急性および慢性腎不全モデル
- Renin Release and Lipid Peroxidation in Renin Granules of the Rat
- Molecular Characterization of Renin in Plasma and Kidney of Sodium-Restricted Rats
- High Molecular Weight Renin in the Mouse Kidney
- Subcellular Localization of Renin in the Mouse Kidney
- Sulfur-Containing Acylamino Acids. I. Syntheses and Angiotensin I Converting Enzyme-Inhibitory Activities of Sulfur-Containing N-Mercaptoalkanoyl Amino Acids(Medicinal Chemistry,Chemical)
- 循環調節因子に関する最近の進歩
- Antihypertensive Effect of Sesamin. II. Protection against Two-Kidney, One-Clip Renal Hypertension and Cardiovascular Hypertrophy
- Antihypertensive Effect of Sesamin. I. Protection against Deoxycorticosterone Acetate-Salt-Induced Hypertension and Cardiovascular Hypertrophy
- ラット実験的高血圧モデルに対するセサミンの予防効果 : 動物
- Enhancement of Norepinephrine and Angiotensin II-Induced Renal Effects by N^G-Nitro-L-arginine, a Nitric Oxide Synthase Inhibitor
- Effects of Phosphoramidon on Endothelin-1 and Big Endothelin-1 Production in Human Aortic Endothelial Cells
- エンドセリン遺伝子発現調節とエンドセリン生合成経路 (血管内皮細胞--研究における最近の動向) -- (エンドセリンをめぐって)
- A Kinin-Generating Amidase Activated by Trypsin in Rat Urine
- Excretion Patterns of Urinary Enzymes Having Amidolytic and Esterolytic Activities in the Urine of Male and Female Rats
- Effects of Actinomycin D and Cycloheximide on the Activities of Catalase and D-Amino Acid Oxidase in the Rat Kidney Cortex during Sodium Restriction
- ル-プ利尿薬 (体液--水・電解質代謝と酸・塩基平衡) -- (利尿剤)
- A Comparative Study on the Measurement of Urinary Kallikrein in the Rat
- Alterations in Renal Enzyme Activities following Sodium Restriction in the Rat
- ラットの各臓器に対するカドミウムの影響(第2報)特にカドミウムの挙動に対するグルタチオン, システイン, サイアミンの影響について
- ラットの各臓器に対するカドミウムの影響(第1報)
- エンドセリンの病態生理学的意義に関する新しい展開
- 食塩感受性高血圧の発症・進展における1型Na〔+〕/Ca〔2+〕交換輸送体の役割の解明
- 心虚血再灌流後の機能障害とノルアドレナリン過剰放出におけるエンドセリン-1の役割
- 実験的循環器疾患モデルの病態発症と進展におけるエンドセリンの役割に関する研究
- ゴマ由来成分の抗高血圧作用に関する研究
- Lack of Ligth/Dark Regulation of Enzymes Involved in the Photosynthetic Carbon Reduction Cycle in Cyanobacteria, Synechococcus PCC 7942 and Synechocystis PCC 6803
- Formulation Study for Lansoprazole Fast-disintegrating Tablet. I. Effect of Compression on Dissolution Behavior
- 2-Methyl-3-(o-tolyl)-6-sulfamyl-7-chloro-1,2,3,4-tetrahydro-4-quinazolinone(metolazone)の利尿作用に関する研究
- 虚血性急性腎不全の発症における腎交感神経系の役割に関する研究
- 虚血性急性腎不全における性差発現に関する研究
- エンドセリンの産生調節と病態への関与
- 次世代の薬理学基礎研究を担う大学院生をいかに確保し育てるか : 私立薬科大学の悩みと苦しみ
- 食事・栄養 セサミンの抗高血圧作用と血管内皮機能改善効果
- 降圧薬の現況
- 腎虚血再灌流障害:発症, 進展機構と障害改善薬
- 高血圧病変の発症と進展におけるエンドセルンET_AおよびET_B受容体の役割
- Cloning and sequence of the SCS2 Gene, Which Can Suppress the Defect of INO1 Exopression in an Inositol Auxotrophic Mutant of Saccharomyces cerevisiae
- 2-Methyl-3-(o-tolyl)-6-sulfamyl-7-chloro-1, 2, 3, 4-tetrahydro-4-quinazolinone (metolazone)の利尿作用に関する研究
- 循環器系疾患に対するフランス海岸松樹皮抽出物(フラバンジェノール)の予防効果
- 血管病変におけるエンドセリン受容体サブタイプの役割とその性差
- EFFECTS OF DIBUTYRYL CYCLIC 3, 5-ADENOSINE MONOPHOSPHATE ON THE RENAL FUNCTION
- A RELEASE OF RENIN FROM DOG KIDNEY CORTEX SLICES